Singapore markets closed
Straits Times Index
3,270.98 -11.90 (-0.36%) Nikkei
27,989.66 -259.58 (-0.92%) Hang Seng
20,185.31 +139.54 (+0.70%) FTSE 100
7,482.37 +42.63 (+0.57%) BTC-USD
23,876.95 +525.85 (+2.25%) CMC Crypto 200
557.41 +14.54 (+2.68%)
IGM Biosciences, Inc. (IGMS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 18.93 |
| Open | 19.14 |
| Bid | 0.00 x 2900 |
| Ask | 0.00 x 800 |
| Day's range | 19.14 - 21.04 |
| 52-week range | 12.67 - 86.91 |
| Volume | |
| Avg. volume | 263,487 |
| Market cap | 883.703M |
| Beta (5Y monthly) | -0.26 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
IGM Biosciences, Inc. (IGMS) Reports Q2 Loss, Misses Revenue Estimates
IGM Biosciences, Inc. (IGMS) delivered earnings and revenue surprises of 7.64% and 99.32%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Biotech Stock Roundup: AXSM to Acquire JAZZ's Drug, IGMS Up on SNY Deal & More
Acquisition and collaboration news from Axsome (AXSM) and IGM Biosciences, Inc. (IGMS), respectively, are a few key highlights from the biotech sector during the past week.
- Zacks
IGM (IGMS) Skyrockets on Collaboration Deal With Sanofi
IGM Biosciences (IGMS) inks a deal with Sanofi (SNY) to discover and develop new therapies based on its proprietary technology, which is set to target oncology, immunology and inflammation targets.
© 2022 Yahoo. All rights reserved.
